CLINICAL_TRIALS
trial_result
· 2014-08-04
Clinical Trial Update: Rilonacept (Arcalyst ®) in the Treatment of Subacromial Bursitis [NA]
Summary
A clinical trial evaluating rilonacept (Arcalyst) for subacromial bursitis has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Keesler Air Force Base Medical Center | Conditions: Subacromial Bursitis | NA | Status: COMPLETED | Results posted: 2014-08-04